The isolation, identification and structure of a new hydroxylated metabolite of benzbromarone in man

References

• Becker H. G. O. Organikum. Organisch-chemisches Grundpraktikum. VEB Deutscher Verlag der Wissenschaften, Berlin 1986; 315
   Google Scholar
• Bonn R., Chasseaud L. F., Grote H., John B. A., Sandrock K., Wood S. G. Biotransformation of benzarone in man. Naunyn-Schmiedeberg's Archiv für Pharmakologie 1986; 332: 50
   Google Scholar
• Bridges J. W., Chasseaud L. F. Progress in Drug Metabolism. Wiley, London and New York 1976–87; vols 1–9
   Google Scholar
• Broekhuysen J., Pacco M., Sion R., Demeulenaere L., Van Hee M. Metabolism of benzbromarone in man. European Journal of Clinical Pharmacology 1972; 4: 125–130
   PubMedGoogle Scholar
• Delbarre F., Auscher C., Amor B. Action uricosurique et antigoutteuse de certains dérivés du benzofuranne. Presse Médicale 1965; 73: 2725–2726
   Google Scholar
• Delbarre F., Auscher C., Olivier J. L., Rose A. Traitement des hyperuricémies et de la goutte pour des dérivés du benzofuranne. Seminaire des Hôpitaux, Paris 1967; 43: 1127–1133
   Google Scholar
• Delbarre F., Deltour G., Rose A., Olivier J. L., Binon F. Recherches dans la serie des benzofurannes. XXXI. Relation entre la structure et effet uricosurique, de certains parahydroxybenzoyl-benzofurannes chez l'homme. Bulletin Chimie et Therapeutique 1968; 6: 470–474
   Google Scholar
• De Vries J. X., Walter-Sack I., Ittensohn A. Analysis of benzbromarone and its metabolites in human plasma and urine by HPLC and GC-MS. Naunyn-Schmiedeberg's Archiv für Pharmakologie 1986a; 334: R56
   Google Scholar
• De Vries J. X., Walter-Sack I., Van de Loo A., Kocher J. Analysis of benzarone in human plasma and urine by HPLC and GC-MS. Composition of the conjugates. Naunyn-Schmiedeberg's Archiv für Pharmakologie 1986b; 332: R96
   Google Scholar
• De Vries J. X., Walter-Sack I., Van de Loo A., Kocher J. Determination of benzarone in human plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. Identification of the conjugates. Journal of Chromatography 1986c; 382: 167–174
   PubMed Web of Science ®Google Scholar
• De Vries J. X., Walter-Sack I., Ittensohn A. Analysis of benzbromarone in human plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. Journal of Chromatography 1987a; 417: 420–427
   PubMed Web of Science ®Google Scholar
• De Vries J. X., Walter-Sack I., Löffler W. The biotransformation of benzbromarone in humans. Characterisation of a new metabolite by gas chromatography-mass spectrometry. Klinische Wochenschrift 1987b; 65(Suppl X)10
   Google Scholar
• De Vries J. X., Tauscher B., Wurzel G. Constituents of Justicia pectoralis Jacq. 2. Gas chromatography/mass spectrometry of simple coumarins, 3-phenylpropionic acids and their hydroxy and methoxy derivatives. Biomedical and Environmental Mass Spectrometry 1988; 15: 431–417
   Google Scholar
• De Vries J. X., Krauss D. Mass spectral analysis of phenprocoumon and O-alkyl-phenprocoumons. Biomedical and Environmental Mass Spectrometry 1989a; 18: 224–232
   Google Scholar
• Eichelbaum M. Defective oxidation of drugs: Pharmacokinetic and therapeutic implications. Clinical Pharmacokinetics 1982; 7: 1–22
   PubMed Web of Science ®Google Scholar
• Ferber H., Vergin H., Hitzenberger G. Pharmacokinetics and biotransformation of benzbromarone in man. European Journal of Clinical Pharmacology 1981; 19: 431–435
   PubMedGoogle Scholar
• Goodwin B. Handbook of Intermediary Metabolism of Aromatic Compounds. Chapman and Hall, London 1976
   Google Scholar
• Grote H., Sandrock K. Ger. Offen. DE. 3342624, 29.3.84, 1984, Benzarone derivatives and their uses in treating venous and arterial ailments. Chemical Abstracts, 101, 54904v
   Google Scholar
• Hathway D. E. Foreign Compounds Metabolism in Mammals. Chemical Society, London 1970–9; vols 1–6
   Google Scholar
• Heel R. C., Brcdgen R. N., Speight T. M., Avery G. S. Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricemia. Drugs 1977; 14: 349–366
   PubMed Web of Science ®Google Scholar
• Kewitz H., Thomsen T. Taschenbuch der unerwünschten Arzneiwirkungen, E. Weber. G. Fischer Verlag, Stuttgart 1983; 70
   Google Scholar
• Löffler W., Peter A., Galda C., Zöllner N. 1989, To be published
   Google Scholar
• Maurer H. The urinary metabolies of benzbromarone in man. Naunyn-Schmiedeberg's Archiv für Pharmakologie 1988; 337: 149
   Google Scholar
• McLafferty F. W. Ch. 2. Interpretation of Mass Spectra3rd edn. University Science Books, Mill Valley, Calif 1980; 17
   Google Scholar
• McLane K. E., Fischer J., Ramakrishan K. Reductive drug metabolism. Drug Metabolism Review 1983; 14: 741–799
   PubMed Web of Science ®Google Scholar
• Pfeifer S., Gildemeister B., Pohlmann H. Biotransformation von Arzneimitteln. Verlag Chemie, Weinheim 1975; vols 1–3
   Google Scholar
• Seibl J. Ch. 2. Massenspektrometrie. Akadem. Verlagsges, Frankfurt/Main 1974; 18
   Google Scholar
• Tietze L. F., Eicher T. Reaktionen und Synthesen im organisch-chemischen Praktikum. G. Thième Verlag, Stuttgart and New York 1981; 315
   Google Scholar
• Vergin H., Bishop G. B. High-performance liquid chromatographic determination of benzbromarone and the main metabolite benzarone in serum. Journal of Chromatography 1980; 183: 383–386
   PubMed Web of Science ®Google Scholar
• Walter-Sack I. Pharmakokinetik der gebräuchlichen harnsäuresenkenden Arzneimittel. Aktuelle Endokrinologie Stoffwechsel 1982; 3: 171–175
   Google Scholar
• Walter-Sack I., De Vries J. X., Ittensohn A., Weber E. Benzbromarone disposition following single dose application. Evidence for lack of debromination. Klinische Wochenschrift 1987; 65(Suppl. X)5
   Google Scholar
• Walter-Sack I., De Vries J. X., Ittensohn A., Kohlmeier K., Weber E. Benzbromarone disposition and uricosuric action; evidence for hydroxylation instead of debromination to benzarone. Klinische Wochenschrift 1988a; 66: 160–166
   PubMedGoogle Scholar
• Walter-Sack I., Eichelbaum M., De Vries J. X., Weber E. Benzbromarone biotransformation is not related to polymorphic oxidation of sparteine. Klinische Wochenschrift 1988b; 66: 1097–1098
   Google Scholar
• Yü T. F. Pharmacokinetic and clinical studies of a new uricosuric agent-benzbromarone. Journal of Rheumatology 1976; 3: 305–312
   PubMedGoogle Scholar
• Zöllner N., Dofel W., Gröbner W. Die Wirkung von Benzbromaronum auf die renale Harnsäureausscheidung Gesunder. Klinische Wochenschrift 1970; 48: 426–432
   Google Scholar